WeedMD Rx Inc is pleased to announce that Health Canada has officially licenced the company to cultivate medical cannabis for patients across Canada. The approval is in accordance with the Marihuana for Medical Purposes Regulations (MMPR), a set of regulations enacted by parliament in July 2013 concerning the production, distribution and use of medical cannabis in Canada and also pursuant to the Controlled Drugs and Substances Act of Canada.

The license will allow the Company to immediately begin cultivation of medical marihuana in its fully expandable 25,000 square foot facility located at the former Imperial Tobacco plant in Aylmer, Ontario.

“The next phase is to establish a WeedMD standard in producing and selling the highest quality cannabis and also providing unparalleled customer service to all of our future patients,” states Bruce Dawson-Scully, CEO of WeedMD. “In particular, we look forward to working with seniors in long-term care, palliative care, and respite care. Seniors are the fastest-growing population to...